Abbott expanding study of its popular Xience stent

TRENTON, N.J. (AP) -- Abbott Laboratories Inc. is expanding a study of its top-selling heart stent by more than 2,000 patients, who may also be put in a second, landmark stent study meant to find the best way to prevent potentially fatal blood clots....

Read the whole article on AP Health

More from AP Health